Clinical Edge Journal Scan

Presence of migraine and ocular motor cranial nerve palsy: Is there a link?


 

Key clinical point: Migraine was significantly associated with the incidence of ocular motor cranial nerve palsy (OMCNP), with the risk being particularly high among patients with migraine who smoked or had diabetes mellitus.

Major finding: The incidence of OMCNP was significantly higher in patients with vs without migraine (adjusted hazard ratio [aHR] 1.166; 95% CI 1.013-1.343), with the association being strongest among those who smoked (aHR 1.426; 95% CI 1.127-1.803) and had diabetes mellitus (aHR 1.378; 95% CI 1.045- 1.378).

Study details: This was a population-based, observational, retrospective cohort study including 4,053,824 medical beneficiaries; of which 5806 developed OMCNP and 4,048,018 did not develop OMCNP (control population). A subgroup of 111,853 patients had migraine.

Disclosures: This study was supported by a National Research Foundation of Korea grant funded by the Korea government and others. The authors declared no conflicts of interest.

Source: Rhiu S et al. Association between migraine and risk of ocular motor cranial nerve palsy. Sci Rep. 2022;12:10512 (Jun 22). Doi: 10.1038/s41598-022-14621-z

Recommended Reading

In the Quest for Migraine Relief, The Search for Biomarkers Intensifies
Migraine ICYMI
Erenumab effective and well-tolerated in chronic migraine
Migraine ICYMI
Migraine significantly correlates with fetal-type posterior cerebral artery in ischemic stroke
Migraine ICYMI
Migraine: Atogepant effective and well tolerated as preventive treatment
Migraine ICYMI
Women with severe migraine with aura have a higher risk for atrial fibrillation
Migraine ICYMI
Erenumab effective and well-tolerated in chronic migraine
Migraine ICYMI
Commentary: Treating Chronic Migraine and Providing Temporary Relief, July 2022
Migraine ICYMI
Significant preventive effects of eptinezumab in patients with previous unsuccessful migraine treatment
Migraine ICYMI
Galcanezumab leads to conversion from chronic to episodic migraine in real world
Migraine ICYMI
Migraine: Efficacy outcomes and adverse effects of lasmiditan are highly interlinked
Migraine ICYMI